EUVIMEDEUVIMED entdecken
Kohortenstudie

Hematological and Inflammatory Markers in Isotretinoin-Associated Sacroiliitis: A Prospective Cohort Study

Nurcan Metin, Çağrı Turan, Enes Kirik, Zeynep Karaca Ural, Saime Özbek Şebin

Dermatology Practical & Conceptual · 29.10.2026 · 16 (4) · 7274

DOI: 10.5826/dpc.1604a7274 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Dermatology Practical & Conceptual, online erschienen am 29.10.2026. Verfasst von Nurcan Metin und 4 weiteren Autor:innen. Die Arbeit nennt 34 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Low back pain (LBP) and sacroiliitis have been reported during isotretinoin therapy, but the role of inflammatory markers in identifying sacroiliitis remains unclear.

Objectives

This study aimed to determine the frequency of LBP and sacroiliitis during isotretinoin therapy and investigate whether any hematological or inflammatory parameter could help identify magnetic resonance imaging (MRI)-confirmed sacroiliitis.

Methods

This prospective cohort study included 220 patients receiving isotretinoin for moderate-to-severe acne. Patients reporting pain at rest or morning stiffness lasting longer than one hour were referred for MRI. Hematological and inflammatory parameters, including C-reactive protein erythrocyte sedimentation neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR), monocyte-to–high-density lipoprotein ratio (MHR), red blood cell distribution width (RDW)-to-lymphocyte and RDW-to-platelet ratio, systemic immune-inflammation index (SII), and systemic inflammatory response index (SIRI) were compared among patients with MRI-confirmed sacroiliitis, MRI-negative inflammatory LBP, and no LBP.

Results

LBP occurred in 81 patients (36.8%); 59 (26.8%) met the study-defined inflammatory pain criteria, and 22 (10.0%) had mechanical pain. Six MRI-eligible patients declined imaging. Sacroiliitis was identified in 22 patients, representing 10.0% of the enrolled cohort, 10.3% after excluding MRI refusals. No significant between-group differences were observed in the evaluated hematological or inflammatory parameters (all p>0.05).

Conclusions

Isotretinoin-associated sacroiliitis occurs with notable frequency. The evaluated markers did not differ significantly among the groups. Clinical assessment and MRI may be more informative than inflammatory markers in distinguishing isotretinoin-associated sacroiliitis from MRI-negative inflammatory LBP. Further studies are needed to establish their diagnostic utility and investigate alternative biomarkers for identifying isotretinoin-associated sacroiliitis.

Zitieren

APA

Metin, N., Turan, Ç., Kirik, E., Ural, Z. K., & Şebin, S. Ö. (2026). Hematological and Inflammatory Markers in Isotretinoin-Associated Sacroiliitis: A Prospective Cohort Study. Dermatology Practical & Conceptual, 16(4), 7274. https://doi.org/10.5826/dpc.1604a7274

Vancouver

Metin N, Turan Ç, Kirik E, Ural ZK, Şebin SÖ. Hematological and Inflammatory Markers in Isotretinoin-Associated Sacroiliitis: A Prospective Cohort Study. Dermatology Practical & Conceptual. 2026;16(4):7274. doi:10.5826/dpc.1604a7274

BibTeX
@article{Metin2026,
  author = {Metin, Nurcan and Turan, Çağrı and Kirik, Enes and Ural, Zeynep Karaca and Şebin, Saime Özbek},
  title = {Hematological and Inflammatory Markers in Isotretinoin-Associated Sacroiliitis: A Prospective Cohort Study},
  journal = {Dermatology Practical & Conceptual},
  year = {2026},
  volume = {16},
  number = {4},
  pages = {7274},
  doi = {10.5826/dpc.1604a7274}
}
Kostenlos starten →